In Swedish
Pressmeddelande

New Board Member

M.Sc. Göran Beijer was elected as a new board member of Alertix at an extraordinary general meeting on the 17th of December 2019.

Göran Beijer has a long and deep experience of management within Life Science from larger companies like Pharmacia/Pfizer, AstraZeneca and GE, but also from smaller companies like Tamro, Uppsala Imanet, Cerbo och Ilya Pharma. Mr Beijer has also participated in a large number of startup companies as a business coach both at Kalmar Science Park and Uppsala Innovation Center. Presently Göran Beijer is CEO at Dicot AB, Uppsala, Sweden.

- We welcome Göran Beijer as a new member of the board! His broad experiences within the Life Science field will be very valuable for Alertix in order to reach our high objectives to develop and commercialize products in veterinary diagnostics, says Anne-Charlotte Aronsson, chairman of Alertix’ board.

Göran Beijer, new board member – I look forward to participate in Alertix’ board as I see large prospects for Alertix to reach commercial success with products on the growing global veterinary diagnostic market.

Alertix Canine

Assay for early detection, monitoring and screening of tumor diseases in dogs. The assay is available to veterinary clinics and laboratories in Sweden and Scandinavia.
Read more about Alertix Canine

Alertix Feline

Assay for early detection, monitoring and screening of tumor diseases in cats. The assay is under development.
Read more about Alertix Feline
Under development

Alertix Equine

Assay for early detection, monitoring and screening of tumor diseases in horses. The assay is under development.
Under development
Read more about Alertix Equine

About cancer in companion animals

Did you know that our companion animals are afflicted by cancer as often as humans? Dogs and cats share not only our living environment but also our lifestyle. Because of this they are exposed to the same risk factors for cancer. Veterinary care is getting better and better at treating cancer in companion animals. But the crucial factor of success is that the disease is detected in time.

Read more about cancer in companion animals